Is BioNTech Stock Really Headed to $119?

Eric Volkman, The Motley Fool
·2-min read
Is BioNTech Stock Really Headed to $119?
Is BioNTech Stock Really Headed to $119?

BioNTech (NASDAQ: BNTX), a previously little-known biotech that has become a leading coronavirus stock, is well positioned to rise 40%. BioNTech vaulted to prominence on its collaboration with global pharmaceutical industry giant Pfizer. No coronavirus vaccine candidate has successful passed through a series of clinical trials to be approved by a major regulator.